Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

65992 1510824253HCLSReviewUkraineNovember2017.pdf
Energy Boardroom

Valeant adds cash and a CVR to its Allergan bid, but will that $50M-plus be enough?

28.05.2014 / Fierce Pharma

As promised, Valeant has raised its original $47 billion offer for Allergan. And as expected, that offer comprises more cash than the original. Whether it'll be enough to win over the California company? That remains to be seen.

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: